Get started
NATCO Pharma LimitedNATCO Pharma LimitedNATCO Pharma Limited

NATCO Pharma Limited

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

NATCOPHARM trade ideas

Natco PharmaDate 12.09.2024 Natco Pharma Timeframe : Weekly Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Natco Pharma cash from the operating activity was Rs 1,196.40 Cr. Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Natco Pharma has a Debt to Equity ratio of 0.06 , which is a strong indication for the company. EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Natco Pharma , the EPS growth was 109.10 % which is good for the company. Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Natco Pharma has OPM of 45.87 % which is a good sign for profitability. ROE: Natco Pharma have a healthy ROE of 25.38 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits. Regards, Ankur
NSE:NATCOPHARM
by AnkurSingh
Natco - Short term DARVAS technical trade Natco - Short term technical trade Fundamentals MCAP- 28000 Cr PE - 17.22 < Industry PE of 35.55 PEG Ratio is 1 Debt to Equity is 0.06 and ICR is 99 ROE is 26%, ROCE is 30% ( 5yr ROCE is 15%) Sales growth is 42%, 5yr Sales growth is 13% Profit Growth is 100%, 5yr Profit growth is 17% Promoter holding is 50% Latest results - excellent Technicals CMP - 1566 Bullish - Above EMA 9, 21,63, 200 on daily charts , RSI(14) is 75 Commentary Based on the Darvas box method, I expect Natco pharma to continue trading up. With CMP 1571, it has breached its own all time high with good volumes. As you can see the volumes yesterday was well over the 20 day moving average volume. I expect the trend to continue. The below targets are to ride this wave and catch as much upside as possible with little downside risk. Target : 1689 Stop Loss : 1420 (If already invested) , more conservative stop loss would be 2-3% below CMP Disclosure 1 - Invested Disclosure 2 - Not SEBI Registered Disclosure 3 - This is Not investment advice. Treat it as educational
NSE:NATCOPHARMLong
by harishnarayan2579
Natco Pharma Limited - Breakout Setup, Move is ON...#NATCOPHARM trading above Resistance of 1514 Next Resistance is at 1957 Support is at 1164 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:NATCOPHARMLong
by MandeepSinghKohli
Natco Pharma Limited - Breakout Setup, Move is ON...#NATCOPHARM trading above Resistance of 1090 Next Resistance is at 1514 Support is at 942 Here are previous charts: Chart is self explanatory. Levels of breakout, possible up-moves (where stock may find resistances) and support (close below which, setup will be invalidated) are clearly defined. Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
NSE:NATCOPHARMLong
by MandeepSinghKohli
NATCO PHARMA LTD ANALYSIS 24 MAY 24 LONG NATCO PHARMA LTD ANALYSIS 24 MAY 24 LONG Investment type : short term (3-12 mnths) Cmp: 1025 R:R= 1:2 Pattern formed : Inverted head and shoulder Expected gains : 7% - 16.50% Bullish levels : - Level 1 : 1068.20 Level 2 : 111.6.10 Level 3 : 1193.30 SL: 932.20 this technical analysis is purely for education purpose only we did not recommend to invest as per our analysis for investment plz consult financial advisor . did you see how perfect inverted head and shoulder pattern was formed .
NSE:NATCOPHARMLong
by believe_in_your_dreams2517
6
Natco Pharma, the road ahead?Its been a journey of parallel channels for Natco Pharma share price and one believes that it will continue to tread within the broad confines of the longer term monthly channel Price has now found the resistance area of the channel which started from the lows of the covid (in blue). However, with the earnings on lenalidomide still some 15-18 months away from reaching peak levels, atleast in volume terms, by that time the street should hear expected positive news on some of the points listed below: - new successful para IV filings and launches from existing tentative or final approved list, - fixing the usfda cloud over kothur formulations plant, - traction on the much anticipated brownfield acquisition, - their CAR T investment growing into something tangible in value terms, - substantial increase in foreign subsidiary business - domestic formulation sales getting boost due to possible semalglutide launch - scaling up of crop health science business therefore looking at the hanging man on WCB I believe that whether for profit booking or geo political or general broader market sentiment it can correct in the immediate shorter term, however, the bullish thesis remains for the fundamental reasons enumerated above.. The first target from here seems to be around 2500 which can be plotted either by box breakout (from 2017 highs) or a rounding bottom (from 2021 highs) or simply the width of the blue parallel channel if and when it breaks out... The principle of polarity suggests that price may not close below the line plotted by taking the highs of 2017 and 2021 (the pink dotted line) this area should be our longer term stop loss and a time to revisit the bullish thesis.
NSE:NATCOPHARMLong
by Rocky_Chow
Welcome to the month of volatility for the Magic Pill February 2024 is the month of volatility and true to form even technical resistance lines are hovering above .. the final decision of the usfda over the kothur plant inspection will be out and the q3 expected blip in the results due to the accounting policy of the booking sales and profit share of gRevlimid drug .. Meanwhile the API plant in Manali, Chennai is back running post a brief halt in production due to flooding issues in the vicinity and the US lawsuit against the company has been dropped while the export oriented production units of the company must be busy manufacturing gRevlimid for the new calendar year at higher volumes than the previous year.. bottom line.. hold her steady!
NSE:NATCOPHARMLong
by Rocky_Chow
Time has come for Natco to repeat the cycleExplaining the current impasse in fibonacci terms: > In the previous upmove 0.618 was the resistance from which share price retreated despite blockbuster earnings coinciding with a slew of negative news.. > After finally exploding through 0.618 level, the next logical resistance level of 0.786 is the new barrier.... Once it overcomes this resistance it may travel all the way to the ATH level >Last May post Q1 results the party had started for Natco Pharma, the cycle may repeat this time around
NSE:NATCOPHARMLong
by Rocky_Chow
Slow and steady Natco getting ready for another hop, skip & jumpWhile the market is rife with speculation of specific stocks and sectors getting a boost due to possible budget discretionary impact I continue to focus on Natco Pharmas steady rise in price as it begins to start the catch up with its stellar business performance... One can see the bollinger band reducing now and the share price coiling up within a triangle like boundary... a successful breakout can lead to 1339 as a possible destination and that also opens up a flag pattern BO which can ultimately lead to 1500+ Its just my personal opinion of what the Q1 results may throw up if the same is positive... have kept a stop loss of close below 1120 technically speaking, from a trading perspective... fundamentally it merits a higher pecking order in the pharma stable but the market is what it is... no point arguing with it
NSE:NATCOPHARMLong
by Rocky_Chow
Natco pharma flying highNatco pharma can double from here with in few years. Sl below the trend line. Chart is self explanatory. Please follow the price action & take the trade as per your appetite. The information provided here is only for educational purpose. The information provided here is not intended to be any kind of financial advice, investment advice, and trading advice. Investment in stock market is very risky and trading stocks, options and other securities involve risk. The risk of loss in stock market can be substantial. Moreover, I am not a SEBI registered analyst, so before taking any decision or before investing in any Share consult your financial advisor and also do your analysis and research. Request your support and engagement by liking and commenting & follow to provide encouragement.
NSE:NATCOPHARMLong
by peacemaker202444
NATCO PHARMA: A Multiyear Breakout Set to Double Your Investment Investment Advice by Goodluck Capital (SEBI Registered) Buy Natco Pharma NSE:NATCOPHARM Buy Range- 1210 - 1220 Target- 1950 - 1960 Potential Return- 60-62% Approx investment period 12 - 14 months TECHNICAL ANALYSIS NSE:NATCOPHARM (1) Back in 2017, Natco Pharma encountered several rejections around the 1,050 level, leading to a subsequent decline. (2) The 500 level has emerged as a crucial support point, allowing the stock to bounce back from this threshold. (3) Although the stock made an attempt to surpass its trendline resistance in July 2021, it ultimately fell short, resulting in another correction before finding support at the 500 level once more. (4) Since March 2023, the stock has been on an upward trajectory, successfully breaking through the resistance level in July 2024. Following this significant multi-year breakout , there is a strong expectation that the stock will remain above the breakout zone, paving the way for a robust upward rally. ● ENTRY & EXIT LEVELS - Look for the best buy levels between 1,210 and 1,220, as this is also the breakout level. However, if the stock begins to consolidate at that level and subsequently breaks out, the upper boundary of this consolidation could present another lucrative entry point. - Based on the chart analysis, it appears that there is a 60% upside potential for this stock, hovering around the 1,950-1,960 level. Moreover, there is a possibility that the stock may surpass this level. FUNDAMENTAL ANALYSIS NSE:NATCOPHARM ● PE RATIO - The stock's current PE stands at 16.9, slightly higher than the 1-year median PE of 14.2 but lower than the 5-year median PE of 26.3. - With an industry PE of 36.6, the stock appears undervalued. ● PB RATIO - The present PB ratio for this stock stands at 3.96, indicating a slightly high valuation but not reaching overvalued territory. ● DEBT TO EQUITY RATIO - The company's debt to equity ratio of 0.06 indicates that it is nearly debt-free. ● PROFIT & LOSS ANALYSIS - Over the last three years, this stock has experienced a remarkable compounded annual sales growth rate of 25%. - The cumulative profit increase over the past three years has been an impressive 49%, indicating a strong upward trend. - The profit margin has seen a significant boost, rising to 44% from 35% YoY. - The EPS growth for FY24 is remarkable, soaring to 77.5 compared to just 39 in FY23. ● CASH FLOW ANALYSIS - There is a substantial increase in operating cash flow, jumping by almost 43% to 1,212 crore from 849 crore in FY23. ● SHAREHOLDING PATTERN - The promoters have consistently held their stakes at 49.71% over the past three quarters. - Over the last four quarters, FIIs have been steadily increasing their investments, in contrast to DIIs who have been offloading their stakes.
NSE:NATCOPHARMLong
by GoodluckCapital
5
NATCO PHARMA! This research focused Pharma looks great.The chart looks good in all three timeframes, Daily, Weekly and Monthly. - Box Breakout Pending (Daily Timeframe) - Double Bottom (Monthly Timeframe) - Near ATH. - If crosses with momentum, we can get 1200+, 1400+ levels easily. - Fundamentally very Good. --- Quarterly, Net Profit (213 --> 386). EPS (11.88 --> 21.57) --- Yearly, Net Profit (715 --> 1388). EPS (39.18 --> 77.51) For educational Purposes only. Not a buy/sell advice.
NSE:NATCOPHARMLong
by azuriste
Crucial levelYou might be thinking I have natco and I am I'm good profitable position but what next? Don't worry! Natco is its crucial level tomorrow or possible next day everything would be clear, as it's in its 52 week high plus its formed Dogi at daily TF and there is also frequency line present there that would lead to little corrrction but everything would be clear tomorrow further a trending move is expected that could throw price upto 10% up or down hence as per market mood I believe it would break all the obsticals. Analysis is based on newton's 1st law. In Crux bullish possibility is around 80% For further info and next stock analysis follow me and drop stocks or index name.
NSE:NATCOPHARM
by Thunder0034
2
NATCOPHARM - CUP AND HANDLE FORMATION (BO FROM SUPPLY ZONE)Hi All, This idea is about Natco Pharma Fundamentals Market Cap - 21712 Cr Stock PE - 15 ROE - 25.9% ROCE - 30% Promoter Holding - 49.7 Quick Ratio - 3.42 D/E - 0.06 NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. Technicals Since May 21, NATCO has formed a complete CUP and HANDLE formation on weekly chart and has now sustained the breakout for over 2 weeks. The earlier supply zone is now acting as demand zone indicating positive price action. This is for mid/long term investors only Hope you enjoy the idea, Happy Trading, Thanks, Stock-n-Shine
NSE:NATCOPHARMLong
by Stock-n-Shine
2
Trading Plan for Natco PharmaHello Trading community and my friends so as we all know that our Trading it should must contains some logics based on price action, indicators and trading strategies etcetera so i find out here some logics for my upcoming trade in Natco pharma sharing with all of you hope all of you like it. So as we can see on provided daily chart that price gives a very bullish breakout of 16th February 2024 with the closure candle of 15% that day and after came down and seems that it is retesting breakout and trying to bounce from there with the help of 50 Day moving average too. So mates i make a very simple trading plan for this trade that after recent swing high of (1100 levels) price came down and tried to move above in breakout direction and getting rejections from 985 levels after retesting i marked this level as a strong resistance area so if we will get a closing above that resistance we can see the recent swing high again as a target one for this trade, and if price will break recent swing high too and closes above we can see a measured target of between swing high and swing low made after breakout and that is more 19% from recent swing high. 930 will act as a good support after the activation of long side trade which earlier was a strong resistance. This publication is meant for only learning purpose, it is not any kind of trading advice. Best Regards- Amit (Do boost my publication if you really like it mates) “Do more of what works and less of what doesn’t”. - Steve Clark
NSE:NATCOPHARMLong
by AMIT-RAJAN
25
Natco Pharma Ltd: - A Prescription for Profits!Natco Pharma Ltd: From Cup to Breakout - A Prescription for Profits! Technical Analysis: Cup and Handle Formation: Natco just completed a textbook cup and handle pattern. It's like the stock was preparing a perfect cup of bullish tea, complete with a handle for easy holding! Breakout: Hold onto your stethoscopes! Natco has broken out above resistance with more energy than a kid on a sugar rush. Trend: The uptrend is so strong, it could probably cure the common cold (disclaimer: it can't, but wouldn't that be nice?). Volume: Rising volume confirms the breakout. Traders are piling in faster than hypochondriacs at a pharmacy during flu season. Support: Previous resistance at 959.80 now likely to act as support. It's like the floor and ceiling just played musical chairs! Fundamental Factors: Pharmaceutical sector seeing increased interest. Natco's producing more buzz than a beehive near a coffee plantation. Potential new drug approvals or pipeline developments could be fueling this healthy rally. Risks: After such a strong move, a pullback is possible. Even the best medicines have their side effects! Keep an eye on broader market sentiment and sector-specific news. Trade Idea: Consider long positions with a stop loss below the breakout level. Target the psychological 1,500 level - let's see if Natco can join the 1.5K club! Remember, traders, timing in the market is like timing your antibiotic doses - crucial for the best results! Key Levels to Watch: New support (old resistance): 959.80 Next psychological resistance: 1,500.00 Stop loss consideration: Below 1,150.00 Disclaimer: This analysis is for educational purposes only. Always do your own research and manage your risk. Remember, the stock market, like the pharmaceutical industry, requires careful study and a strong stomach for volatility!
NSE:NATCOPHARMLong
by TRADING-NASA